NCT07642622 Physical Activity Through Health Technology in Axial Spondyloarthritis
| NCT ID | NCT07642622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Axial Spondyloarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-06 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-06 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis (axSpA) to receive exercise recommendations as part of their regular rheumatology care. Researchers want to learn: Whether people with axSpA find the ExerciseRx app easy to use and helpful for supporting regular exercise. Whether using the ExerciseRx app leads to improvements in symptoms, physical function, and disease activity compared with usual care. Participants assigned to the ExerciseRx group will use the app to complete guided exercises for 20-30 minutes, four times per week. They will also receive personalized weekly step-count goals to help increase their physical activity. Researchers will compare outcomes between participants using the app and those receiving usual care.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of axial spondyloarthritis by a rheumatologist * English speaking * Insufficiently active (less than 150 minutes of moderate intensity aerobic activity per week) * Willing to wear a Fitbit for the study duration * Willing to have or create a Google account and download the Google Health app (previously known as the Fitbit app) Exclusion Criteria: * Currently pregnant * International travel or any circumstance causing lack of access to wi-fi/Internet at any point during the study period * Recent or planned surgery that may affect ability to engage in physical activity * Unable to exercise for health reasons, or a provider has recommended against exercising for safety/health reasons * Unable to walk safely without difficulty, or is a fall risk (i.e., 3+ falls in past 6 months) * History of a fall resulting in a fracture or head injury in the past 6 months * Cardiovascular contraindicators for physical activity, or history of cardiovascular problems that may be exacerbated by physical activity, as defined by their rheumatologist * Diabetes causing hypoglycemia following physical activity
Contact & Investigator
Rachael Stovall, MD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT07642622 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Axial Spondyloarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07642622 currently recruiting?
Yes, NCT07642622 is actively recruiting participants. Contact the research team at joychan@uw.edu for enrollment information.
Where is the NCT07642622 trial being conducted?
This trial is being conducted at Seattle, United States, Seattle, United States.
Who is sponsoring the NCT07642622 clinical trial?
NCT07642622 is sponsored by University of Washington. The principal investigator is Rachael Stovall, MD at University of Washington. The trial plans to enroll 40 participants.